Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/14/2025 | $26.00 | Strong Buy → Outperform | Raymond James |
| 2/28/2025 | $43.00 → $35.00 | Overweight → Equal Weight | Barclays |
| 1/7/2025 | $70.00 | Sector Weight → Overweight | KeyBanc Capital Markets |
| 12/12/2024 | $45.00 → $75.00 | Hold → Buy | Deutsche Bank |
| 10/11/2024 | Sector Weight | KeyBanc Capital Markets | |
| 4/25/2024 | $70.00 | Sell → Hold | Deutsche Bank |
| 3/6/2024 | $100.00 | Overweight | Barclays |
| 4/21/2023 | $83.00 | Neutral | Cantor Fitzgerald |
Provides Updated Guidance for 2025; Announces Chief Financial Officer Transition Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Revenue totaled $869.2 million, an increase of 9.2% over the second quarter of 2024 Same facility revenue increased 9.5% compared with the second quarter of 2024, including an increase in revenue per patient day of 7.5% and an increase in patient days of 1.8% Net income attributable to Acadia totaled $30.1 million, or $0.33 per diluted share Adjusted income attributable to Acadia totaled $74.8 million, or $0.83 per
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its second quarter 2025 results on Tuesday, August 5, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Wednesday, August 6, 2025. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States. As of March 31, 2025, Acadia operated a network of 270 behavioral healthcare facilities
Affirms Full Year 2025 Guidance Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Revenue totaled $770.5 million, compared with $768.1 million for the first quarter of 2024 Same facility revenue increased 2.1% compared with the first quarter of 2024, including an increase in patient days of 2.2% Same facility revenue and patient day growth both included an unfavorable year-over-year impact from the leap year of approximately 1.1% Net income attributable to Acadia totaled $8.4 million, or $0.09 per diluted share Adjusted income attributable to Acadia
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
Raymond James downgraded Acadia Healthcare from Strong Buy to Outperform and set a new price target of $26.00
Barclays downgraded Acadia Healthcare from Overweight to Equal Weight and set a new price target of $35.00 from $43.00 previously
KeyBanc Capital Markets upgraded Acadia Healthcare from Sector Weight to Overweight and set a new price target of $70.00
SCHEDULE 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
10-Q - Acadia Healthcare Company, Inc. (0001520697) (Filer)
8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)
Provides Updated Guidance for 2025; Announces Chief Financial Officer Transition Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Revenue totaled $869.2 million, an increase of 9.2% over the second quarter of 2024 Same facility revenue increased 9.5% compared with the second quarter of 2024, including an increase in revenue per patient day of 7.5% and an increase in patient days of 1.8% Net income attributable to Acadia totaled $30.1 million, or $0.33 per diluted share Adjusted income attributable to Acadia totaled $74.8 million, or $0.83 per
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its second quarter 2025 results on Tuesday, August 5, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Wednesday, August 6, 2025. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States. As of March 31, 2025, Acadia operated a network of 270 behavioral healthcare facilities
Affirms Full Year 2025 Guidance Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Revenue totaled $770.5 million, compared with $768.1 million for the first quarter of 2024 Same facility revenue increased 2.1% compared with the first quarter of 2024, including an increase in patient days of 2.2% Same facility revenue and patient day growth both included an unfavorable year-over-year impact from the leap year of approximately 1.1% Net income attributable to Acadia totaled $8.4 million, or $0.09 per diluted share Adjusted income attributable to Acadia
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the opening of its newest acute care hospital, Agave Ridge Behavioral Hospital, located at 3322 S. Ellsworth Road, in Mesa, Arizona. A ribbon-cutting ceremony was held today to mark its grand opening. The first patient admissions are expected to follow in the coming days as the hospital completes its final preparations to provide care for those in need. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240411986178/en/Acadia Healthcare hosts ribbon-cutting ceremony on April 11, 2024, for its new behavioral health hospital in Mesa, Arizona. The new hospital, named Agave R
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the appointment of Dr. Stephanie Eken as the Company's new chief medical officer. Dr. Eken is a psychiatrist with more than two decades of experience across the spectrum of behavioral health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240404108920/en/Acadia Healthcare Appoints Dr. Stephanie Eken as Chief Medical Officer (Photo: Business Wire) "Acadia is thrilled to welcome Dr. Eken as our new chief medical officer," said Chris Hunter, Chief Executive Officer of Acadia Healthcare. "Her experience and expertise will help Acadia set the standard for care across the i
Henry Ford Health, one of the nation's premier academic and integrated health systems, and Acadia Healthcare, the nation's largest stand-alone behavioral healthcare company, today announced the appointment of Emily Sexton as Chief Executive Officer of Henry Ford Behavioral Health Hospital, the new 192-bed inpatient behavioral health hospital being built through a joint venture partnership between Henry Ford and Acadia in West Bloomfield, Michigan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240220715559/en/Henry Ford Health and Acadia Healthcare announced the appointment of Emily Sexton as Chief Executive Officer of Henry For
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)